Literature DB >> 24352850

Pain hypervigilance is associated with greater clinical pain severity and enhanced experimental pain sensitivity among adults with symptomatic knee osteoarthritis.

Matthew S Herbert1, Burel R Goodin, Samuel T Pero, Jessica K Schmidt, Adriana Sotolongo, Hailey W Bulls, Toni L Glover, Christopher D King, Kimberly T Sibille, Yenisel Cruz-Almeida, Roland Staud, Barri J Fessler, Laurence A Bradley, Roger B Fillingim.   

Abstract

BACKGROUND: Pain hypervigilance is an important aspect of the fear-avoidance model of pain that may help explain individual differences in pain sensitivity among persons with knee osteoarthritis (OA).
PURPOSE: The purpose of this study was to examine the contribution of pain hypervigilance to clinical pain severity and experimental pain sensitivity in persons with symptomatic knee OA.
METHODS: We analyzed cross-sectional data from 168 adults with symptomatic knee OA. Quantitative sensory testing was used to measure sensitivity to heat pain, pressure pain, and cold pain, as well as temporal summation of heat pain, a marker of central sensitization.
RESULTS: Pain hypervigilance was associated with greater clinical pain severity, as well as greater pressure pain. Pain hypervigilance was also a significant predictor of temporal summation of heat pain.
CONCLUSIONS: Pain hypervigilance may be an important contributor to pain reports and experimental pain sensitivity among persons with knee OA.

Entities:  

Mesh:

Year:  2014        PMID: 24352850      PMCID: PMC4063898          DOI: 10.1007/s12160-013-9563-x

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  39 in total

Review 1.  Central sensitization in patients with rheumatoid arthritis: a systematic literature review.

Authors:  Mira Meeus; Stijn Vervisch; Luc S De Clerck; Greta Moorkens; Guy Hans; Jo Nijs
Journal:  Semin Arthritis Rheum       Date:  2011-10-28       Impact factor: 5.532

Review 2.  A quantitative review of ethnic group differences in experimental pain response: do biology, psychology, and culture matter?

Authors:  Bridgett Rahim-Williams; Joseph L Riley; Ameenah K K Williams; Roger B Fillingim
Journal:  Pain Med       Date:  2012-03-05       Impact factor: 3.750

3.  Attention to pain and fear of pain in patients with chronic pain.

Authors:  Geert Crombez; Ilse Viane; Christopher Eccleston; Jacques Devulder; Liesbet Goubert
Journal:  J Behav Med       Date:  2012-05-22

4.  Association between comorbid depression and osteoarthritis symptom severity in patients with knee osteoarthritis.

Authors:  Ki Woong Kim; Ji Won Han; Hyung Joon Cho; Chong Bum Chang; Joon Hyuk Park; Jung Jae Lee; Seok Bum Lee; Sang Cheol Seong; Tae Kyun Kim
Journal:  J Bone Joint Surg Am       Date:  2011-03-16       Impact factor: 5.284

Review 5.  Central sensitization: implications for the diagnosis and treatment of pain.

Authors:  Clifford J Woolf
Journal:  Pain       Date:  2010-10-18       Impact factor: 6.961

6.  Sensitization in patients with painful knee osteoarthritis.

Authors:  Lars Arendt-Nielsen; Hongling Nie; Mogens B Laursen; Birgitte S Laursen; Pascal Madeleine; Ole H Simonsen; Thomas Graven-Nielsen
Journal:  Pain       Date:  2010-04-24       Impact factor: 6.961

7.  Discordance between pain and radiographic severity in knee osteoarthritis: findings from quantitative sensory testing of central sensitization.

Authors:  Patrick H Finan; Luis F Buenaver; Sara C Bounds; Shahid Hussain; Raymond J Park; Uzma J Haque; Claudia M Campbell; Jennifer A Haythornthwaite; Robert R Edwards; Michael T Smith
Journal:  Arthritis Rheum       Date:  2013-02

Review 8.  Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9).

Authors:  Karen L Smarr; Autumn L Keefer
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

Review 9.  Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS).

Authors:  Natalie J Collins; Devyani Misra; David T Felson; Kay M Crossley; Ewa M Roos
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

Review 10.  The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia.

Authors:  Yvonne C Lee; Nicholas J Nassikas; Daniel J Clauw
Journal:  Arthritis Res Ther       Date:  2011-04-28       Impact factor: 5.156

View more
  18 in total

1.  Cancer Survivorship-Considering Mindsets.

Authors:  Lauren C Heathcote; Sean R Zion; Alia J Crum
Journal:  JAMA Oncol       Date:  2020-09-01       Impact factor: 31.777

2.  Examining the Impact of a Resilience-Based Hope Intervention on Pain-Evoked Cortisol Response.

Authors:  Nadia I Hossain; Michael E Robinson; Roger B Fillingim; Emily J Bartley
Journal:  J Undergrad Res (Gainesv)       Date:  2018

Review 3.  Racial-Ethnic Differences in Osteoarthritis Pain and Disability: A Meta-Analysis.

Authors:  Ivana A Vaughn; Ellen L Terry; Emily J Bartley; Nancy Schaefer; Roger B Fillingim
Journal:  J Pain       Date:  2018-12-10       Impact factor: 5.820

4.  Minority Aging and Endogenous Pain Facilitatory Processes.

Authors:  Hailey W Bulls; Burel R Goodin; Myriah McNew; Ethan W Gossett; Laurence A Bradley
Journal:  Pain Med       Date:  2015-12-07       Impact factor: 3.750

5.  Pain relief for osteoarthritis through combined treatment (PROACT): Protocol for a randomized controlled trial of mindfulness meditation combined with transcranial direct current stimulation in non-Hispanic black and white adults with knee osteoarthritis.

Authors:  Roger B Fillingim; Adam J Woods; Hyochol Ahn; Samuel S Wu; David T Redden; Song Lai; Hrishikesh Deshpande; Georg Deutsch; Kimberly T Sibille; Roland Staud; Fadel Zeidan; Burel R Goodin
Journal:  Contemp Clin Trials       Date:  2020-09-28       Impact factor: 2.226

6.  During vigilance to painful stimuli: slower response rate is related to high trait anxiety, whereas faster response rate is related to high state anxiety.

Authors:  Timothy J Meeker; Nichole M Emerson; Jui-Hong Chien; Mark I Saffer; Oscar Joseph Bienvenu; Anna Korzeniewska; Joel D Greenspan; Frederick Arthur Lenz
Journal:  J Neurophysiol       Date:  2020-12-16       Impact factor: 2.714

7.  Risk factors for osteoarthritis and contributing factors to current arthritic pain in South Korean older adults.

Authors:  Kyoung Min Lee; Chin Youb Chung; Ki Hyuk Sung; Seung Yeol Lee; Sung Hun Won; Tae Gyun Kim; Young Choi; Soon Sun Kwon; Yeon Ho Kim; Moon Seok Park
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

8.  Evidence for a Priori Existence of Attentional Bias Subgroups in Emotional Processing of Aversive Stimuli.

Authors:  Casper H van Heck; Joukje M Oosterman; Kim M A de Kleijn; Marijtje L A Jongsma; Clementina M van Rijn
Journal:  Front Behav Neurosci       Date:  2017-05-12       Impact factor: 3.558

9.  Health-related quality of life deviations from population norms in patients with lumbar radiculopathy: associations with pain, pain cognitions, and endogenous nociceptive modulation.

Authors:  Wouter Van Bogaert; Koen Putman; Iris Coppieters; Lisa Goudman; Jo Nijs; Maarten Moens; Ronald Buyl; Kelly Ickmans; Eva Huysmans
Journal:  Qual Life Res       Date:  2021-08-03       Impact factor: 4.147

10.  Hypervigilance to pain affects activities of daily living: an examination using the Japanese version of the pain vigilance awareness questionnaire.

Authors:  Hayato Shigetoh
Journal:  J Phys Ther Sci       Date:  2017-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.